300 related articles for article (PubMed ID: 19062099)
21. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones.
Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC
J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587
[TBL] [Abstract][Full Text] [Related]
22. A new bis(3-hydroxy-4-pyridinone)-IDA derivative as a potential therapeutic chelating agent. Synthesis, metal-complexation and biological assays.
Amélia Santos M; Gama S; Gano L; Cantinho G; Farkas E
Dalton Trans; 2004 Nov; (21):3772-81. PubMed ID: 15510305
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy.
Storr T; Merkel M; Song-Zhao GX; Scott LE; Green DE; Bowen ML; Thompson KH; Patrick BO; Schugar HJ; Orvig C
J Am Chem Soc; 2007 Jun; 129(23):7453-63. PubMed ID: 17511455
[TBL] [Abstract][Full Text] [Related]
24. Iron(III) chelating resins II. 3-Hydroxy-4(1H)-pyridinones-sepharose gels.
Feng M; van der Does L; Bantjes A
J Biomater Sci Polym Ed; 1992; 4(2):145-54. PubMed ID: 1486065
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, characterization, and cytotoxicity studies of Cu(II), Zn(II), and Fe(III) complexes of N-derivatized 3-hydroxy-4-pyridiones.
Telpoukhovskaia MA; Rodríguez-Rodríguez C; Scott LE; Page BD; Patrick BO; Orvig C
J Inorg Biochem; 2014 Mar; 132():59-66. PubMed ID: 24393377
[TBL] [Abstract][Full Text] [Related]
26. Alkylaryl-amino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application.
Chaves S; Gil M; Marques S; Gano L; Santos MA
J Inorg Biochem; 2003 Sep; 97(1):161-72. PubMed ID: 14507473
[TBL] [Abstract][Full Text] [Related]
27. Development of a fluorescent chelating ligand for gallium ion having a quinazoline structure with two Schiff base moieties.
Kimura J; Yamada H; Ogura H; Yajima T; Fukushima T
Anal Chim Acta; 2009 Mar; 635(2):207-13. PubMed ID: 19216880
[TBL] [Abstract][Full Text] [Related]
28. Iron binding dendrimers: a novel approach for the treatment of haemochromatosis.
Zhou T; Neubert H; Liu DY; Liu ZD; Ma YM; Kong XL; Luo W; Mark S; Hider RC
J Med Chem; 2006 Jul; 49(14):4171-82. PubMed ID: 16821777
[TBL] [Abstract][Full Text] [Related]
29. Carbohydrate-bearing 3-hydroxy-4-pyridinonato complexes of gallium(III) and indium(III).
Green DE; Ferreira CL; Stick RV; Patrick BO; Adam MJ; Orvig C
Bioconjug Chem; 2005; 16(6):1597-609. PubMed ID: 16287260
[TBL] [Abstract][Full Text] [Related]
30. Design of iron chelators: syntheses and iron (III) complexing abilities of tripodal tris-bidentate ligands.
d'Hardemare Adu M; Torelli S; Serratrice G; Pierre JL
Biometals; 2006 Aug; 19(4):349-66. PubMed ID: 16841245
[TBL] [Abstract][Full Text] [Related]
31. Searching for new aluminium chelating agents: a family of hydroxypyrone ligands.
Toso L; Crisponi G; Nurchi VM; Crespo-Alonso M; Lachowicz JI; Mansoori D; Arca M; Santos MA; Marques SM; Gano L; Niclós-Gutíerrez J; González-Pérez JM; Domínguez-Martín A; Choquesillo-Lazarte D; Szewczuk Z
J Inorg Biochem; 2014 Jan; 130():112-21. PubMed ID: 24200878
[TBL] [Abstract][Full Text] [Related]
32. Hydroxypyridinones with enhanced iron chelating properties. Synthesis, characterization and in vivo tests of 5-hydroxy-2-(hydroxymethyl)pyridine-4(1H)-one.
Lachowicz JI; Nurchi VM; Crisponi G; Jaraquemada-Pelaez MG; Arca M; Pintus A; Santos MA; Quintanova C; Gano L; Szewczuk Z; Zoroddu MA; Peana M; Domínguez-Martín A; Choquesillo-Lazarte D
Dalton Trans; 2016 Apr; 45(15):6517-28. PubMed ID: 26956442
[TBL] [Abstract][Full Text] [Related]
33. Tuning the properties of tris(hydroxypyridinone) ligands: efficient
Imberti C; Chen YL; Foley CA; Ma MT; Paterson BM; Wang Y; Young JD; Hider RC; Blower PJ
Dalton Trans; 2019 Mar; 48(13):4299-4313. PubMed ID: 30860215
[TBL] [Abstract][Full Text] [Related]
34. The effect of chelating agent on the separation of Fe(III) and Ti(IV) from binary mixture solution by cation-exchange membrane.
Kir E; Cengeloğlu Y; Ersöz M
J Colloid Interface Sci; 2005 Dec; 292(2):498-502. PubMed ID: 16038918
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and iron(III)-chelating properties of novel 3-hydroxypyridin-4-one hexadentate ligand-containing copolymers.
Zhou T; Kong XL; Liu ZD; Liu DY; Hider RC
Biomacromolecules; 2008 May; 9(5):1372-80. PubMed ID: 18373358
[TBL] [Abstract][Full Text] [Related]
36. Bifunctional 3-hydroxy-4-pyridinones as effective aluminium chelators: synthesis, solution equilibrium studies and in vivo evaluation.
Irto A; Cardiano P; Chand K; Cigala RM; Crea F; De Stefano C; Gano L; Sammartano S; Santos MA
J Inorg Biochem; 2018 Sep; 186():116-129. PubMed ID: 29885988
[TBL] [Abstract][Full Text] [Related]
37. Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.
Cusnir R; Imberti C; Hider RC; Blower PJ; Ma MT
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28075350
[TBL] [Abstract][Full Text] [Related]
38. A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease.
Shin RW; Kruck TP; Murayama H; Kitamoto T
Brain Res; 2003 Jan; 961(1):139-46. PubMed ID: 12535786
[TBL] [Abstract][Full Text] [Related]
39. Hydroxypyridinone Derivatives: A Fascinating Class of Chelators with Therapeutic Applications - An Update.
Chaves S; Piemontese L; Hiremathad A; Santos MA
Curr Med Chem; 2018; 25(1):97-112. PubMed ID: 28359230
[TBL] [Abstract][Full Text] [Related]
40. Towards a new attenuating compound: a potentiometric, spectrophotometric and NMR equilibrium study on Fe(III), Al(III) and a new tetradentate mixed bisphosphonate-hydroxypyridinonate ligand.
Crisponi G; Nurchi VM; Pivetta T; Gałezowska J; Gumienna-Kontecka E; Bailly T; Burgada R; Kozłowski H
J Inorg Biochem; 2008 Jul; 102(7):1486-94. PubMed ID: 18299150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
